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SulTlmary 
Nucleosome-specific T  helper (Th) cells provide major histocompatibility complex class II- 
restricted,  cognate  help  to  nephritogenic  antinuclear autoantibody-producing B  cells in  lupus. 
However, the lupus Th cells do not respond when components of the nucleosome, such as free 
DNA or histones, are individually presented by antigen-presenting cells. Thus critical peptide 
epitopes for the pathogenic Th cells are probably protected during uptake and processing of the 
native nucleosome particle as a whole. Therefore, herein we tested  145  overlapping peptides 
spanning all four core histones in the nucleosome. We localized three regions in core histones,  one 
in H2B at amino acid position  10-33 (H2BI0_33), and two in H4, at position  16-39 (H41t~_39) 
and position 71-94 (H471.,~4), that contained the peptide epitopes recognized by the pathogenic 
autoantibody-inducing Th cells of lupus.  The peptide autoepitopes also  triggered the patho- 
genic Th cells of(SWR ￿  NZB)FI lupus mice in vivo to induce the development of  severe lu- 
pus nephritis. The nucleosomal autoepitopes stimulated the production ofThl-type cytokines, 
consistent with immunoglobulin IgG2a, IgG2b, and IgG3 being the isotypes of nephritogenic 
autoantibodies induced in the lupus mice. Interestingly, the Th cell epitopes overlapped with 
regions in histories that contain B cell epitopes targeted by autoantibodies, as well as the sites 
where histones contact with DNA in the nucleosome. Identification of the disease-relevant au- 
toepitopes in nucleosomes will help in understanding how the pathogenic Th cells of sponta- 
neous systemic lupus erythematosus emerge, and potentially lead to the development of pep- 
tide-based tolerogenic therapy for this major autoimmune disease. 
T 
he production of nephritogenic antinuclear autoanti- 
bodies  in  SLE  is  driven  by  cognate  interactions be- 
tween select populations ofautoinunune Th and B cells (1-8). 
To further study this pathogenic mechanism, the special auto- 
immune  Th  cells  of lupus  were  cloned  from  (SWR  X 
NZB)F1 (SNFI) ~ mice with lupus nephritis, as well as from 
nephritic patients with SLE (3,  4, 7).  In the SNF1 model, 
representative pathogenic autoantibody-inducing Th clones 
rapidly  induce  immune-deposit  glomerulonephritis  when 
transferred into young preautoimmune mice (4). Although 
heterogeneous, the TCR-CDR3 junctional regions of the 
pathogenic Th clones recurrendy contain anionic residues, 
suggesting selection by autoantigens with reciprocally charged 
residues that were presented to them by the anti-l)NA  B 
cells they preferentially helped  (4,  8,  9).  Indeed "-~50% of 
such pathogenic Th clones that respond to nucleosomal an- 
~Abbreviations used in this paper: aa, amino acid sequence; dsl)NA, double 
stranded I)NA; SI, stimulation index; SNF  I, (SWIL X NZB)FI; ssl)NA, 
single stranded I)NA. 
tigens and nucleosome-specific T cells are detectable in SNF 1 
mice long before they produce pathogenic autoantibodies 
(5). Moreover, immunization ofpreautoimmune SNF1 but 
not normal mice with native nucleosome particles induces 
severe lupus  nephritis  (5).  The pathogenic  autoantibody- 
inducing Th cells of human lupus are also specific for nu- 
cleosomal  antigens  (8).  Indeed,  nucleosome-specific  au- 
toantibodies that are induced by such Th cells (4-8) play a 
central  role  in  the  development of lupus  nephritis  (5,  8, 
10-12).  Thus, nucleosomes are primary immunogens that 
initiate the cognate interaction between the pathogenic Th 
and B cells of lupus. 
Identification of the critical Th cell autoepitopes in nu- 
cleosomes will help in  understanding how the pathogenic 
Th cells of lupus emerge, and potentially lead to the devel- 
opment  of peptide-based  tolerogenic  therapy.  Mononu- 
cleosomes consist of  double stranded DNA (dsDNA)  wrapped 
around  a  core octamer of histones:  two  each  of histones 
H2A, H2B, H3, and H4 (13).  The fact that mononucleo- 
some presentation could be blocked by leupeptin and pep- 
statin  A  that  are-inhibitors  of endosomal  proteases,  sug- 
2459  J. Exp. Med. ￿9  The Rockefeller University Press ￿9 0022-I 007/9~b,~06/~.~/1 t $2.00 
Volume 183 June 1996 2459-2469 gested  that  peptides  from  the  histone  component  of the 
nucleosomes harbor the  relevent epitope(s)  for  the patho- 
genic Th  cells  (5).  However,  the  nucleosome-specific Th 
clones do not respond to free histones (5). This result sug- 
gested two possibilities: (a) the generation of critical histone 
epitope(s) may be dependent on the efficient uptake of the 
native nucleosome particle by specific receptors  on APCs; 
or  (b)  the  critical histone epitopes  may be protected  from 
degradation during processing by being bound to DNA  in 
the intact nucleosomes (5). Therefore, to identify the criti- 
cal epitopes, we adopted an alternative approach:  a total of 
145  overlapping  15-mer  peptides,  spanning all  four  core 
histones,  were  synthesized  and  the  nucleosome-specific, 
pathogenic  autoantibody-inducing Th  clones  were  tested 
for response to these synthetic peptides.  Herein, we report 
that  the  lupus Th  cells  do  indeed recognize  determinants 
from three different regions of the core histones, and these 
peptide epitopes can trigger pathogenic Th cells in vivo to 
precipitate severe lupus nephritis in SNF 1 mice. 
Materials and Methods 
Mice.  BALB/c, NZB, SWIK, and (BALB/c ￿  SW1K)F 1 mice 
were purchased from The Jackson Laboratory (Bar Harbor, ME). 
SNF  1 hybrids were  bred at our animal facility. Periodic  testing 
showed that the mice were free of specific pathogens, such as mouse 
hepatitis virus. Female mice were used for the experiments. 
Cloned Th Cell Lines and Hybridomas.  Cloned Th  cell lines and 
hybridomas used here were previously derived from SNF  1 mice 
with lupus nephritis and maintained as described (3-5).  Cloned 
Th lines were rested for 12 d before the assays. The B  cell lym- 
phoma APC, A20 (I-Ad), was grown as described (5). 
Antibodies.  The following mAbs were obtained from the Ameri- 
can Type Culture Collection (1Kockville,  MD)  and used as de- 
scribed (5, 6): anti-I-A  a (HB3), anti-I-A  b,a,q (TIB120), anti-HSA 
(TIB183), anti-Thy-l.2 (TIB99), anti-CD8 (TIB211), and anti- 
CD3 (145-2Cll). 
Cytokine ELISA.  Anti-IL-2, anti-IFN-% anti-IL-4, and anti- 
IL-10, capture and biotinylated revealing antibody pairs and the 
respective standards were purchased from PharMingen (San Di- 
ego,  CA).  Streptavidin-horseradish peroxidase and the  substrate 
3,3',5,5'-tetramethyl  benzidine-dihydrochloride were  purchased 
from Sigma Chemical Co.  (St. Louis, MO).  The  cytokines were 
qnantitated according to the manufacturer. 
Synthesis of Peptides.  All the peptides used for the results shown 
here, were either synthesized by pin method or Fmoc chemistry 
(Chiron Mimotopes, San Diego, CA). Overlapping 15-mer pep- 
tides  (acetyl-peptide-diketopiperizine)  were  synthesized  span- 
ning the entire stretch of all four core histone (H2A, H2B,  H3, 
and H4) sequences (GenBank). Each 15-met overlapped the pre- 
ceding amino acid by 12 residues. Purity of  the peptides was checked 
by amino acid analysis. Longer, 24-mer histone peptides were syn- 
thesized as follows: H416_39  , H471_94, and H2B10_33. The "control" 
peptide was an I-Aa-binding 17-mer ovalbumin (OVA323_339)  pep- 
tide that is immunogenic in vivo (14).  The 24- and the  17-mer 
were purified by HPLC and analyzed by mass  spectrometry for 
purity.  Relevant  peptides  of interest  were  also  synthesized  at 
Tufts University School of Medicine (Boston, MA), and results 
were  similar to  those  obtained with  the  peptides  from  Chiron 
Mimotopes (data not shown). 
Splenic CD4 + T  Cells and APCs.  The  splenic  CD4 +  T  cells 
were  isolated as reported earlier (5,  6),  from 3-4-too-old SNF  1 
mice by nylon wool column followed by the lysis of CD8  +  T 
cells  and contaminating B  cells.  For peptide presentation, either 
mitomycin C-treated A20 B cell lymphoma or irradiated B+Md0 
APC were prepared as described (5). 
Help for IgG autoantibody production * 
Th clor#e  Anti-ssDNA  Anti-dsDNA 
H/L-3A  15.0  22.5 
H/L9.37  6.7  4.2 
H/L9.10  6.6  2.2 
H16B6  22.4  6.6 
H/L9.7  11.0  2.9 
H12C4  41.8  2.6 
H/L9w.7  26.2  7.0 
H15G9  44.5  3.6 
H15E3  16.3  2.4 
L- 1A  20.7  28.0 
L-9.2  8.0  2.8 
H16B11  202.1  7.1 
H12FA  6.0  3.3 
H10B5  12.5  2.0 
H16G10  18.0  15.3 
TCR usage  Nucleosome 
Response 
VWJ~z  V[~/J[~  (SI) 
19.1/41  4/2.6  24,0  Figure  1.  Summary of patho- 
8/14  4/2.6  7.4  genic autoantibody-inducing  Th 
clones derived  from  SNF  1 mice 
2.5/23  4/2.1  4.8  with lupus nepb_ritis  (4, 5, 9). (L) 
Cloned Th fines; (H) Th hybri- 
2.5/37  2/1.5  99.2  domas  derived  directly  from 
23.1/27  2/2.6  11.8  splenic T ceils. (H/L) Cloned Th 
lines that were fused with TCR- 
13/47  8.3/2.4  34.0  negative  BW5147  thymoma to 
obtain Th hybridomas, after ini- 
2/15  8.2/2.1  26.7  tial  functional  characterization 
(4, 5, 9). H/L hybridomas were 
3/28  14/1.4  5.8  retested to confirm that their nu- 
cleosome  specificity  and  path-  16/13  14/1.1  1.3  ogenic  autoantibody-inducing 
8/36  8.2/1.6  1.0  ability were still intact. SI for the 
nucleosome-reactive  Th  clones 
10/40  8.3/2.1  1.0  are shown in bold.  (*) Help  for 
IgG autoantibody  production is 
10114  8.2/2.1  2.2  expressed as fold increase in anti- 
14/15  8.3/1.1  1.1  body  production  when  Th 
clones were cocultured with syn- 
2.5/42  1/2.2  1.5  geneic B cells, as compared with 
control  cultures  containing  B 
19.1/37  1/2.6  2.9  cells alone. Optimal results from 
10 to 15 experiments are given. 
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Figure  2.  IL-2 production by 
nucleosome-specific, pathogenic 
autoantibody-inducing  Th  cell 
clones  in  response to  histone 
H2B  and H4 synthetic peptides 
using A20 as APCs. Mitomycin 
C-treated A20 were pulsed with 
1 I~M of the respective peptides 
for 18 h and were used as APCs. 
A representative of three to five 
experiments is shown. SD within 
each  experiment  was  ~10%. 
IL-2  production  could  not  be 
detected in background cultures 
without  peptide,  whereas anti- 
CD3  antibody  induced  the Th 
clones to produce >2,000 pg/ml 
of IL-2  (not  shown). Synthetic 
peptides  (15-mer) spanning  all 
four histones were tested with all 
15 Th clones described in Fig. 1, 
and only the ones that responded 
are shown. 
Proliferation and Cytokine Assays.  Fresh splenic CD4 + T  cells 
(5  ￿  10S/well)  were  cocultured  in  triplicate  with  irradiated 
B+M~b or mitomycin C-treated A20 lymphoma (106 cells) APCs, 
and different concentrations of control or test peptide in a 200-1~I 
final volume  in  HL-1  serum-free  medium  (Hycor Biomedical 
Inc., Irvine, CA) for 96 h  in flat-bottom 96-weU plates (Costar 
Corp., Cambridge, MA). 18 h before harvesting, 1 I~Ci [3H]thy- 
midine/well was added. Stimulation index (SI) was calculated by 
dividing the mean counts per minute incorporated in cultures of 
T cells plus APCs and test peptide by the mean counts per minute 
in control peptide cocultures. For cytokine assays, culture super- 
natants were removed from duplicate coculture wells after 24-48 h. 
Autoantibody Quantitation.  IgG class autoantibodies to ssDNA, 
dsDNA, histones, and nucleosomes (histone-DNA complex) were 
estimated by ELISA (5, 6). Sera were diluted 1:100 and heat inac- 
tivated before use. Sera from normal BALB/c mice were used as 
negative control. Anti-DNA mAbs 564  and 205  were  used to 
generate standard curves (5). 
Pathogenicity of  Histone-defived Peptides In Vivo.  18-wk-old prene- 
phritic SNF  1 females (nine mice per group) were injected with 
either H2B10_33,  H416_39,  H47t_94 ,  or control OVA323_336  peptides 
(100  txg/mouse) emulsified in CFA. The animals received three 
more booster injections at 2-wk intervals with  (50 ~,g/mouse) 
peptides adsorbed on alum (Pierce Chemical Co., Rockford, IL). 
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The mice were monitored (4-6) and killed when they developed 
persistent proteinuria (two  consecutive weekly readings of 300 
mg/dl or greater). Sera were collected and blood urea nitrogen 
(BUN)  was  measured  by Azostix (Miles Laboratories, Elkhart, 
IN). Kidney sections were stained with hematoxylin and eosin for 
grading of glomerulonephritis by a blinded observer as described 
(4-6). 
Results 
Summary of the Properties of Pathogenic Th  Clones of Lupus. 
In earlier studies, we  isolated 268  T  cell clones from  the 
spontaneously  activated splenic  T  cells of 10  SNF  1 mice 
with lupus nephritis (4). About 15% of these T  cell clones 
had the ability to preferentially augment the production of 
IgG  anti-DNA  autoantibodies,  and  representative patho- 
genic Th clones (H/L-3A, L-1A) rapidly induced immune- 
deposit glomerulonephritis when transfered into young pre- 
autoimmune  mice  (4,  6).  A  summary of the properties of 
15  such  pathogenic  autoantibody-inducing  Th  clones  is 
given in Fig. 1. The Th clones use a variety of TC1L genes 
(Fig. 1), but their CDR.3 junctional regions contain anionic H2A  Peptides  H3  Peptides 
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H2B  Peptides  H4  Peptides 
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Figure 3.  Proliferative responses of splenic CD4 § T  cells from unmanipulated, 4-mo-old SNFi mice to overlapping 15-mer peptides spanning the en- 
tire sequences of histones H2A, H2B, H3, and 1-14.1-mo-old SNF~ splenic B+ M~b were irradiated and pulsed with t  p~M of the respective peptides for 
18 h and used as APCs. A representative of three experiments is shown. The results are expressed as stimulation indices. SD within each experiment was 
<10%. The background counts with control OVA peptide in these experiments were typically 350-900 cpm, and >3 SD above background cpm (ho~/- 
zontal line) was considered to be stimulatory. 
residues  suggesting that the antigenic determinants recog- 
nized by these TCRs might have reciprocally charged resi- 
dues (4, 9).  Indeed, half of these Th clones recognize nu- 
cleosomal antigens in the context of I-A  d (5, and Fig.  1). 
All the Th clones augmented IgG anti-DNA autoantibody 
production by autologous B  cells by 6-200-fold  (Fig.  1, 
data from ref.  4),  and their ability to induce IgG antinu- 
cleosome antibodies was even higher (5). 
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Figure 4.  Cytokine production by splenic CD4 + 
T  cells  from  unmanipulated,  3-4-mo-old  SNF~ 
mice to  H2B  and H4 synthetic peptides using ei- 
ther  A20  ~lled  bars)  or  l-too-old  SNF  1  splenic 
B+M~b (unfilled  bars) as APCs. Representative re- 
sults from three such experiments are shown. 
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Figure  5.  Analysis of amino 
acid sequences of histones H2B 
and H4. The highlighted regions 
contain  the  pathogenic  Th  cell 
epitopes and corresponding pep- 
tides (24-met) were used for im- 
munization.  The  regions that 
overlap with certain moti~ of in- 
terest are designated by numbers: 
(1) Amphipathic regions (15); (2) 
Rothbard  motif (16);  (3)  I-A  a 
binding  motif  (14);  (4)  I-E  d 
binding motif (17); (5) autoanti- 
body binding  regions (18, 19); 
and  (6)  Histone-DNA  contact 
regions (13). 
Identification of Pathogenic T h Cell Determinants in Core His- 
tones.  To identify the critical Th cell epitopes, a panel of 
15-mer overlapping peptides spanning the  entire  sequence 
of the core histones H2A, H2B, H3, and H4 were synthe- 
sized. The peptides were tested at 0.1,  1, and 10 IxM, using 
A20  (I-A  a)  APCs,  for  their  ability  to  stimulate  IL-2  pro- 
duction by the panel of 15 pathogenic autoantibody-induc- 
ing Th  clones  of SNF 1 mice.  1-1xM  concentration  of the 
peptide was the optimum and was used for the assays. One 
cluster of overlapping peptides from histone  H2B and two 
clusters from histone H4 peptides consistently induced IL-2 
production  by 6  of the  15  pathogenic  Th  clones  (Fig.  2). 
All six of these pathogenic autoantibody-inducing Th clones 
had responded  to native nucleosomes  (5, and Fig.  1). The 
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Figure 6.  Proliferative response of 4-mo-old,  splenic CD4 + T cells to 
the longer (24-mer) histone peptides, H2B10_33, H4tt_39, and H471 94 using 
l-too-old B +Mqb from respective strains as APCs. Experiments were car- 
ried out as described in Fig. 3. A representative of three experiments is 
shown. The results are expressed as stimulation indices. SD within each 
experiment was <10%. Anti-CD3  stimulation elicited a SI of 33-44  in 
the strains tested. 
Th done  H9.7  responded to a cluster of overlapping pep- 
tides  from H2B in the  amino acid sequence  (aa)  region  of 
10-33  (Fig. 2). Clone H9.37 responded to a cluster of pep- 
tides from histone H4 in the aa 13-33 region  (Fig. 2). The 
rest of the pathogenic  Th clones responded to two clusters 
ofpeptides within  histone  H4 aa 13-39 and 67-93  regions 
(Fig.  2).  The  other histone  peptides  did not stimulate  any 
of the Th clones. 
Response to Core Histone Synthetic Peptides by T  Cells  from 
Unmaniputated SNF  1 Mice.  To further test the in vivo rel- 
evance of these peptides, we screened them for their ability 
to  stimulate  proliferation  of freshly isolated  CD4 +  T  cells 
from 3-4-mo-old,  prenephritic  SNF~  mice  (Fig.  3).  SNF] 
lupus mice (but not normal mice) at this age spontaneously 
have  nucleosome-specific  T  cells  without  any  deliberate 
immunization  (5).  Peptides spanning certain regions of H3 
and  H4  stimulated  greater proliferation  (SI  of 5-15)  than 
peptides from H2A and H2B  (SI of 2.5-2.8),  but cytokine 
responses were equally high (see below). 
Cytokine Induction by the Histone Peptides.  The  peptides 
in H2B and H4 that were thus localized for stimulating the 
pathogenic Th clones as well as the splenic T  cells (Figs.  2 
and 3), were further tested for their ability to induce  cyto- 
kine  production  in  the  freshly  isolated  splenic  CD4 +  T 
cells  from  unmanipulated,  3-4-too-old  SNF 1 mice.  The 
peptides  from  histones  H2B  (region  10-33)  and  H4  (re- 
gions  13-39  and  67-93)  induced  T  cells  from  the  SNF, 
mice  to  produce  Thl-type  cytokines,  IL-2,  and  IFN-~/ 
(Fig.  4), but not IL-4, although anti-CD3  antibody did in- 
duce  the production  of >2,000  pg/ml of IL-4 by these T 
cells  (data  not  shown).  Although  the  H2B  peptides  had 
elicited  relatively low proliferative  response  (Fig.  3),  they 
stimulated  high  amounts  of IL-2  (500-1,200  pg/ml)  and 
IFN-3' (100-500  pg/ml)  production,  like the  H4 peptides 
(Fig. 4). 
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Figure 7.  Cytokine production by CD4 § T cells 
from unimmunized 3-mo-old SNF  1 mice in spon- 
taneous response to the longer histone peptides us- 
ing  either A20  (filled bars), or  1-mo-old  SNF  1 
splenic B+M~b (unfilled bars) as APCs. R.epresenta- 
five results from three such experiments are shown. 
Selection of Histone Peptides  for In Vivo Studies.  We  synthe- 
sized slightly longer 24-merpeptides,  H2B10_33  , H416.39  , and 
H471_94  , to cover the amino acid sequences in the overlap- 
ping  15-mer peptides  of H2B and  H4 that  stimulated the 
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Figure  8.  Incidence  of severe glomerulonephritis in prenephritic SNF  1 
mice immunized with histones H2Blo_33, or H416-39, or H471_9,, or control 
0VA323.339 synthetic peptides. Nine mice per group were immunized first 
at 18 wk age with 100 p.g of the relevant peptides in CFA, followed by 
three more injections at 2-wk intervals with 50 I~g of peptides adsorbed 
in alum. The mice received the last injection at 24 wk of age, except for 
those that had already developed severe nephritis. 
pathogenic autoantibody-inducing Th clones as well as the 
freshly isolated CD4 + T  cells from SNF1 mice (Figs. 2-4). 
Even though some H3 and H2A peptides stimulated SNF1 
splenic T  cells (Fig. 3), they were not selected because they 
did not stimulate any of the pathogenic Th clones. The se- 
quences from histones H2B (H2B10_33) and H4 (H416_39 and 
H471_94), which were  selected  for their  stimulatory  ability 
of SNF1 Th cells,  contained amphipathic  and "tkothbard" 
T  cell epitope  motifs  designated by numbers  1 and  2,  re- 
spectively, in Fig. 5 (15,  16), but there were no I-A  a (num- 
ber 3 in Fig. 5; 14) or I-E  a (number 4 in Fig. 5; 17) binding 
motifs.  Nevertheless,  the  nucleosomal  epitopes  are  pre- 
sented by I-A  a molecules on A20 APCs to the SNF  1 (H-2  d/q) 
T  cells (5, and Fig. 4). The stimulatory peptides overlapped 
with histone regions known to contain B  cell epitopes that 
are recognized by antihistone  autoantibodies  (number 5 in 
Fig. 5; 18, 19), as well as histone-DNA contact sties  (desig- 
nated by number 6 in Fig. 5; 13). 
In  Vivo Relevance  of Selected Longer Histone Peptides.  The 
larger  peptides  H2B10_33  ,  H416_39  ,  and  H471_94 were  first 
tested for their ability to stimulate CD4 + T  cells from 4-5- 
mo-old unimmunized SNF1 mice, the parental strains SWR 
and  NZB  (I-A  d and  I-Aq,  respectively),  and  from MHC 
haplotype-matched,  nonautoimmune  BALB/c  (I-A  a)  and 
(SWtk  ￿  BALB/c) F1 mice. As expected,  all  three longer 
peptides  also  induced  a  proliferative  response  in  T  cells 
from  SNF~  mice  (Fig.  6).  Histone  H4  peptide,  H471_94, 
2464  Nephritogenic Th Cell Epitopes in Murine Lupus Table 1.  Antinuclear Autoantibodies in the Serum (Mean  U/ml +  SEAl) of Histone Peptide-immunized SNFI Mice 
Serum levels of IgG autoantibodies against: 
Immunogen  ssDNA  dsDNA  Histones  Nucleosome 
OVA323_339  0.83 +  0.25  1.32  •  0.50  8.24 •  1.71  2.08 +  0.46 
H2B10_33  72.66  -4- 26.66  18.36  •  8.66  9.96 -+ 1.73  11.43  +  4.61 
(<0.05)  (>0.1)  (>0.1)  (<0.01) 
H416_39  25.53  •  8.15  11.03  •  4.14  38.85  +  1.24  18.95  +  7.45 
(<0.025)  (<0.1)  (<0.025)  (<0.01) 
H471_94  50.82  •  22.72  12.14  +  7.60  45.88 +  12.2  20.63  +  9.37 
(<0.01)  (<0.05)  (<0.01)  (<0.1) 
Augmentation  of autoantibody  production in 21-wk-old SNF  1 mice after immunization  with histone peptides. 1Lesults are expressed as mean  + 
SEM. P values (Mann-Whitney U test) in comparison to corresponding results in control 0VA323_339  immunized mice are given in parentheses. 
elicited the  highest  response  (SI  of 14),  whereas  H416_39 
peptide induced a SI of 8.5.  The 24-mer H2B10_33 peptide 
evoked a higher SI of 12.5  (Fig. 6),  as compared with the 
smaller  15-mer  H2B  peptides  spanning  the  same  region 
(Fig.  3).  The  control  OVA323_339, a  known  I-A  d binding 
peptide,  did not  elicit any  proliferative response  in  these 
unimmunized mice. These peptides did not stimulate CD4 + 
T  cells from any of the other strains tested (Fig. 6), whereas 
anti-CD3  antibody stimulated T  cells from  all the  strains 
(data not  shown).  The  longer histone  peptides, like their 
15-mer  counterparts  (Fig.  4),  induced  the  production  of 
Thl-type  cytokines  by  CD4 +  T  cells  of unmanipulated 
SNF1 mice, but not Th2 cytokines (Fig. 7). 
Histone Peptides Accelerate the Devolpment of Severe Glomero 
utonephritis in SNF1 Mice.  18-wk-old prenephritic SNF  1 mice 
injected with synthetic peptides from histones H2B (H2B10_33) 
or  H4  (H416_39 or  H471_94  )  in  adjuvant  developed severe 
nephritis  much  earlier than  age-matched  SNF~  mice  in- 
jected with control peptide OVA323_339 in adjuvant (Fig. 8). 
Mice  were  considered  to  have  severe  glomerulonephritis 
when they had persistent proteinuria of >1300 mg/dl for 2 wk 
and BUN  levels at  >130  mg/dl;  after killing at  this stage, 
their kidneys showed a 3+  to 4+  grade of nephritis by his- 
topathology. After only 3 wk from initial immunization, at 
21  wk of age, 66.6%  of the mice immunized with H471_94 
had severe glomerulonephritis, whereas none of the mice in 
the other three groups had developed severe nephritis (P = 
0.009,  Fisher's exact test). 5 wk after the initial injection (at 
23 wk of age), 66.6%  of the H471_94  , 55.5% of the H416_39  , 
and  44.4%  of the  H2B10_33 peptide-immunized mice  had 
developed severe glomerulonephritis, but none of the con- 
trol OVA323_339-immunized mice (P <0.01) had. 9 wk after 
the start of immunization (at 27 wk of age), 88.8%  of his- 
tone  H416_39 and  H471_94 peptide-immunized  mice,  and 
Table 2.  Proliferative Response (Mean cpm +  SEM) of T  Cells from Peptide-immunized  SNF  1 Mice 
Proliferative response of splenic CD4 + T cells with APCs and 
Immunogen  Medium  0VA323_339  H2BI0_33  H416_39  H471_94 
0VA323_339  817 -+ 98  35,650 +  2,810  2,710  +  890  1,658  +  133  3,360  +  759 
(43.6)  (3.3)  (2.0)  (4.1) 
H2B10_33  922  +  109  477 +  186  30,783  +  3,714  4,384 -  795  5,048 _  715 
(0.5)  (33.4)  (4.8)  (5.5) 
H416_39  742  -  130  1,078  +  186  1,300  +  213  32,641  +  3,524  3,418  +  462 
(1.5)  (1.8)  (44.0)  (4.6) 
H471_94  785  +  165  1,191  +  240  1,880  +  339  2,707  +  442  28,230  +  2,483 
(1.5)  (2.4)  (3.5)  (36.0) 
Recall responses to the immunizing histone and ovalbumin peptides. The proliferative responses from six mice of each group are shown as mean 
cpm +  SEM. SI are in parentheses. 
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Figure 9.  IL-2 and IFN-"/production by splenic CD4 + T cells of im- 
munized SNF  1 mice in response to relevant histone peptides. Splenic CD4 + 
T cells of SNF1 mice from each of the immunized groups, were cultured 
in presence  of control  OVA323_339  (O)  or relevant  immunizing histone 
peptides (El) using SNF~ B+M~b as APCs, and the supernatants were as- 
sayed for various cytokine production.  Results shown are values from in- 
dividual mice of each group and the mean value is indicated by the hori- 
zontal line. 
66.6%  of H2B10_33-immunized  mice  developed  severe lu- 
pus  nephritis,  whereas  the  control  group  had  a  22.2%  dis- 
ease incidence  (P  =  0.015).  At 33 wk of age,  H416_39-  and 
H471_ga-immunized  mice had  100% and H2B10_33  mice had 
88.8%, whereas OVA323_339-injected mice had only a 55.5% 
incidence of severe lupus nephritis  (P =  0.082).  By 40 wk 
of age,  100% of the histone peptide-immunized  groups vs. 
only 66.6% of the control OVA323_339 peptide-injected ani- 
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Figure  10.  IL-4 and IL-10 cytokine response by splenic CD4 + T cells 
from the immunized SNF l mice shown in Fig. 9. The experiments were 
done as in Fig. 9.  Results  for the relevant  immunizing histone  peptide 
(O) or anti-CD3 stimulation  ([]) are shown after subtracting background 
values (T cells plus APCs with control OVA peptide) in each case. Values 
from individual mice from each group are shown with the mean value in- 
dicated by the horizontal line. 
mals  had  developed  the  disease  (P  =  0.206;  Fig.  8).  Re- 
markably,  the H471_94 peptide precipitated the disease more 
rapidly  than  the  H2B10_33  and  H416_39 peptides  during  the 
period 3-8 wk after the imtial immunization, i.e., between 21 
and 26 wk age (P <0.01-P  <0.02).  By 27 wk of age, both 
8416_39  and  H471_94 peptides were performing better in in- 
ducing lupus  nephritis  than  H2B10_33  (Fig.  8).  The  control 
OVA3a3_339-immunized  mice  had  the  same  rate  of lupus 
nephritis  as that ofunimmunized  or PBS/CFA-immunized 
SNF 1 mice (5). 
2466  Nephritogenic Th Cell Epitopes in Murine Lupus Anti--nuclear Autoantibody Levels in Histone Peptide Immunized 
Mice.  in unmanipulated SNF 1 lupus mice, the nephrito- 
genic autoantibodies are specific for ssDNA,  dsDNA,  and 
nucleosomes (5).  The levels of IgG autoantibodies with at 
least two of the pathogenic specificities were significantly 
elevated  in  the  mice  immunized  with  histone  peptides 
when tested at 21  wk of age (Table I). At later ages from 
30 wk and beyond, there were no significant differences in 
serum autoantibody levels between the control and the his- 
tone peptide-immunized mice. This is expected, since ele- 
vated serum levels of autoantibodies precede the develop- 
ment  of severe  nephritis  by  several  weeks,  and  marked 
fluctuations occur due to tissue deposition (5). 
Recall Response  to  Immunized  Histone  Peptides by  Splenic 
CD4 + T  Cells.  In the histone peptide-immunized mice, 
splenic CD4 + T cells had a significant proliferative response 
to the respective immunizing peptide at the time of killing 
(21-30 wk age; Table 2). The histone peptides also elicited 
a  lower level  of "background"  or  "spontaneous"  T  cell 
proliferative response  in  the  other  groups  of SNF~ mice 
that  had  not  received  the  respective  immunogen.  The 
strongest spontaneous  response was  elicited by H471_,)4 in 
SNF 1 mice immunized with one of the other peptides. The 
background stimulation across the groups by these histone 
peptides is expected as the SNF~ mice develop spontaneous 
lupus nephritis and possess nucleosomal peptide-specific T 
cells at the ages tested even without deliberate immuniza- 
tion (Figs. 6 and 7). 
Cytokine  Production Pattern by  CD4 + T  CeUs  from Immu- 
nized SNFj Mice.  The  immunizing histone  peptides  also 
induced the production of Thl  cytokines IL-2 and IFN-~/ 
by splenic CD4 + T  cells from SNF1 mice immunized with 
the corresponding peptide (Fig. 9). However, IL-4 and IL-10 
production in response to the peptides was not significantly 
above background levels  (Figs.  7  and  10),  although  anti- 
CD3  antibody could stimulate production of the Th2 cy- 
tokines by the same T cell population (Fig.  10). 
Discussion 
Localization of the peptide autoepitopes in the core his- 
tones definitively establishes  that nucleosomes are the pri- 
mary immunogens for the spontaneously arising pathogenic 
Th cells of lupus, and excludes the possibility that nucleo- 
somes  stimulate  indirectly  by  augmenting  the  display  of 
other endogenous antigens or by increasing cytokine pro- 
duction by the APC (20). Herein, we have not only identi- 
fied the peptide autoepitopes for the antinuctear autoanti- 
body-inducing  Th  clones  but  have  also  established  their 
disease relevance in vivo. 
The nucleosome-specific, pathogenic autoantibody-induc- 
ing  Th  clones  that responded  to  the  peptides  from H2B 
and H4 core histones, each have a single functional TCR 0r 
and 13 chain (4, 9). Yet, some of the Th clones responded 
to peptides from two different regions of H4 that did not 
have an apparent primary sequence homology except for the 
presence of charged residues (Figs. 2 and 5). Moreover, Th 
clones that responded to the same histone peptides (Fig. 2) 
have different TCRs (9, and Fig.  1). Such examples of de- 
generate recognition have been described for other T  cells 
(21-23). This plasticity of TCR repertoire has implications 
for the selection of autoimmune Th cells in the thymus or 
in the periphery by environmental molecular mimics. 
The overlapping peptides from the same regions of H2B 
(aa 10-33) and H4 (aa 16-39 and 71-94) core histones that 
were recognized by the pathogenic autoantibody-inducing 
Th clones also  stimulated splenic T  cells from unmanipu- 
lated SNF1 mice, ex vivo. These peptides induced the pro- 
duction  of high  levels  of Thl-type  cytokines  IL-2  and 
IFN-~/by the freshly isolated splenic T  cells from the lupus 
mice.  This finding is consistent with  the  observation that 
the pathogenic anti-DNA autoantibodies of SNF1 mice are 
predominandy  IgG2a,  IgG2b,  and  IgG3  in  isotype  (5), 
which are induced by Thl  cells  (24).  Immune complexes 
consisting of these particular IgG isotypes mediate comple- 
ment fixation, as well as activation of inflammatory cells, by 
binding to their Fc~/receptors, both of which are the hall- 
marks of lupus nephritis. 
Interestingly,  the  lupus  Th  cell  stimulatory  regions  of 
H2B and H4 did contain T  cell epitope motifs that have 
been previously described (15, 16), as well as B cell motifs, 
i.e., the sites localized to be the targets of antihistone auto- 
antibodies (18,  19). Thus, autoimmune B cells with specific- 
ity for the overlapping epitopes in the nucleosomal histones 
could present the autoepitopes to the Th cells efficiently af- 
ter uptake and processing (4, 5, 7, 25, 26). indeed, our ear- 
lier work indicated that a single pathogenic lupus Th clone 
could help a dsDNA-, a ssDNA-, a histone-, a high mobil- 
ity  group  protein-,  or a  nucleosome-specific B  cell in  a 
polyclonal population,  because  each  of those  B  cells  by 
binding to its  respective epitope on the whole chromatin, 
could take it up and process it, and then present the relevant 
peptide Th-epitope in the chromatin to the Th clone (5, 8). 
With the ongoing autoinmmne response and intermolecular 
help,  epitope  spreading  may  occur  across  other  histone 
components of the nucleosome particle (Fig.  3),  as well as 
other relevant autoantigens associated with pathogenic au- 
toantibody production (5, 8, 25, 27-30). In addition to the 
B cell epitope sites, the peptides of interest to the Th cells 
of lupus, contained the sites in histones that remain in con- 
tact with DNA  in the  nucleosome (13  and Fig.  4).  This 
feature could protect the epitopes from degradation during 
processing by APCs, which could explain why the native par- 
ticle is more immunogenic for the lupus Th cells. 
The H2B and H4 peptides that were specifically recog- 
nized by the spontaneously arising, pathogenic autoantibody- 
inducing Th cells of lupus mice during the natural history 
of their disease were also pathogenic in vivo. Immunization 
ofprenephritic SNF t mice with H2B~0_33  , H4~6_3,  .  or H47~_94 
peptide  markedly  accelerated  the  development  of severe 
glomerulonephritis and augmented the production of patho- 
genic antinuclear autoantibodies. The H47~_,)4 peptide pre- 
cipitated lupus nephritis earliest, next the H416_39  , followed 
by  H2BI0_33 (Fig.  8).  Interestingly,  the  nucleosomal  core 
2467  Katiyaperumal  et al. histone H4 is also recognized by pathogenic autoantibody- 
inducing Th cells  in human lupus (9),  but the critical pep- 
tide  epitopes  have not yet been identified.  Splenic T  cells 
from the immunized SNF1 mice that had developed severe 
nephritis,  again  produced  Thl-type  cytokines  on  rechal- 
lenge  with  the  immunizing  peptide.  The  skewing  to  a 
Thl-type response was probably not due to immunization 
with  CFA because alum was also used.  Moreover,  T  cells 
from  unimmunized  SNFI  mice  also  produced  Thl-type 
cytokines in spontaneous responses to these particular pep- 
tides  (Figs.  4 and 7).  This result is consistent with the class 
of nephritogenic autoantibodies produced by these mice as 
mentioned above. 
How could autoimmunization to nucleosomes, the nor- 
mal product of apoptosis (31),  occur in lupus? The histone 
peptide  epitopes  that  we  have  identified  here  could  be 
cryptic, thus allowing nucleosome-specific T  cells to escape 
to the periphery  (27).  However,  normal mice do not de- 
velop lupus upon immunization with nucleosomes whereas, 
lupus  mice do,  and they have nucleosome-primed  T  cells 
early in life even without any deliberate  immunization  (5). 
Abnormal antigen processing due to the prevalence of nu- 
cleosome-binding B cells in lupus mice, and other intrinsic 
defects of the  immune  system  of lupus in  handling cross- 
reactive  environmental  antigens  (5,  25,  26,  32-35)  could 
contribute  to  the  presentation  of  the  nucleosomal  au- 
toepitopes.  Indeed,  MHC  class  I-bound histone  peptides 
have  been  isolated,  but  so  far,  no  histone  peptides  have 
been  detected  among  the  naturally  processed  peptides 
eluted from MHC  class  II molecules from nonlupus APCs 
(36). We can begin to address these issues  as well as antici- 
pate the development ofpeptide-based tolerogenic therapy 
in lupus with the identification of the critical autoepitopes. 
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